NCOR1P1

Across TCGA pan-cancer cohorts, NCOR1P1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated NCOR1P1 data layer compared with 17 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher NCOR1P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NCOR1P1 expression acts as an unfavorable survival marker.

STAD, SKCM, and HNSC are the cancer types where NCOR1P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.184	0.730	.001	33	view →
SKCM	OS	Median	All	0.339	0.785	<.001	27	view →
HNSC	OS	Median	All	0.069	0.768	<.001	24	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
BLCA	DFS	Median	III,IV	0.166	0.572	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

NCOR1P1–STAD (OS)

Open the STAD breakdown →